SBIO Increases on Biotech’s Sustained Rebound
July 20, 2022 at 13:18 PM EDT
A surge in biotech stocks that began in mid-June is lasting longer than skeptics expected, with no signs of slowing down. The ALPS Medical Breakthroughs ETF (SBIO) gained 7.74% in June as positive drug trial data and M&A activity in the biotech space outweighed investors’ broad market recession fears. The fund has increased 28.95% since [...] The post SBIO Increases on Biotech’s Sustained Rebound appeared first on ETF Trends .